| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/30/2004 | EP1432437A2 Human tissue urokinase type plasminogen activator formulation |
| 06/30/2004 | EP1432414A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same |
| 06/30/2004 | EP1432411A1 Timed, sustained release multi-particulate dosage forms of propranolol |
| 06/30/2004 | EP1432410A2 Process for the preparation of fast dissolving effervescent dosage form |
| 06/30/2004 | EP1432409A1 Granulate or powder for producing coating or binding agents for medicaments |
| 06/30/2004 | EP1432408A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 06/30/2004 | EP1432407A1 Lisinopril compositions having large-particle dcpd |
| 06/30/2004 | EP1432406A2 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support |
| 06/30/2004 | EP1432405A1 Ibuprofen salt emulsifiers and cream formulations containing same |
| 06/30/2004 | EP1432404A1 Edible composition and dosage form comprising an edible shell |
| 06/30/2004 | EP1432403A2 Liposome loading with metal ions |
| 06/30/2004 | EP1432402A2 Compositions for delivery of drug combinations |
| 06/30/2004 | EP1432312A1 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
| 06/30/2004 | EP1432310A2 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 06/30/2004 | EP1267916B1 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 06/30/2004 | EP1264548A4 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 06/30/2004 | EP1246607A4 Proteoliposomes containing an integral membrane protein having one or more transmembrane domains |
| 06/30/2004 | EP1244418B1 Oil-in-water type cosmetic or dermatological preparations |
| 06/30/2004 | EP1237543A4 Effervescent histamine h2 antagonist composition |
| 06/30/2004 | EP1227817B1 Ciclesonide-containing aqueous pharmaceutical composition |
| 06/30/2004 | EP1206281B1 Formulation containing moxifloxacin and sodium chloride |
| 06/30/2004 | EP1169063B1 Treatment of intracellular infection |
| 06/30/2004 | EP1075253B1 Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use |
| 06/30/2004 | EP1069889B1 Partikulärer wirkstoffträger für die pulmonale applikation |
| 06/30/2004 | EP1035882B1 Automatic liquid injection system |
| 06/30/2004 | EP0996465B1 Compositions and articles for reducing the effects of inflammation |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | EP0910341B1 Pharmaceutical composition to be administered orally |
| 06/30/2004 | EP0876817B1 Remedy for keratoconjunctival diseases |
| 06/30/2004 | EP0841897B2 Physically active antimicrobial gel for cosmetic products |
| 06/30/2004 | CN2621713Y Cervical plug for treating cervical erosion |
| 06/30/2004 | CN2621668Y Instant magnetic medicinal plaster |
| 06/30/2004 | CN2621667Y Black plaster with intermediate net fabric |
| 06/30/2004 | CN1509186A Composition containing epigallocatechin gallate |
| 06/30/2004 | CN1509185A Medicinal composition |
| 06/30/2004 | CN1509181A Composition contaiuing asiasari radix extracts for protecting brain cells and improving memory |
| 06/30/2004 | CN1509172A Pirenzepine ophthalmic gel |
| 06/30/2004 | CN1509167A Process for producing stable enteric sugar-coated tablet |
| 06/30/2004 | CN1509166A Liposome composition for improved intracellular delivery of therapeutic agent |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1509164A System for delivering consmetics and pharmaceuticals. |
| 06/30/2004 | CN1509162A Cosmetics |
| 06/30/2004 | CN1509144A Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 06/30/2004 | CN1508182A Tablet coating |
| 06/30/2004 | CN1507918A Transdermal promotor glycerin triacetate |
| 06/30/2004 | CN1507909A Freeze-dried powder injection for treating carido-cerebrovascular disease and preparing method thereof |
| 06/30/2004 | CN1507902A Method for processing puffed product of chinese medicine |
| 06/30/2004 | CN1507896A Chinese medicime liposome for treating viral hepatitis B and preventing liver cell from fibriform and preparing method thereof |
| 06/30/2004 | CN1507866A Bulley aconitne transdermal paster |
| 06/30/2004 | CN1507864A Endermatic feeding preparation of anti parastic medicine containing benzimidazole |
| 06/30/2004 | CN1507862A Complex acetaminophen vitamin C dispersion tablet and preparing method thereof |
| 06/30/2004 | CN1507861A Trimebutine maleate tablet and preparing method thereof |
| 06/30/2004 | CN1507857A Elemene fatty emulsion injection and preparing method thereof |
| 06/30/2004 | CN1507856A Medicinal plaster for depressing hyper tension |
| 06/30/2004 | CN1507855A Diphenyl acetic acid plaster for anti-inflammatory and analgesic |
| 06/30/2004 | CN1507854A Amphotericin B Liposome and preparing method thereof |
| 06/30/2004 | CN1507813A Composite nutrient food and processing method thereof |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155408C Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 06/30/2004 | CN1155406C Nitrogen oxide generation inhibitor |
| 06/30/2004 | CN1155396C Medicine for guiding cancer cell differentiation and its use on treating and preventing cancer |
| 06/30/2004 | CN1155394C Microcapsule coated trace element product and its producing method |
| 06/30/2004 | CN1155392C High-molecular block copolymer-medicine compound preparation |
| 06/30/2004 | CN1155388C Orally administrable solid ribavirin dosafe forms and process for making them |
| 06/30/2004 | CN1155386C Nailpolish having function of resisting psoriasis |
| 06/30/2004 | CN1155385C Formulation comprising testosteron undecanoate and castor oil |
| 06/30/2004 | CN1155384C Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 and production technology thereof |
| 06/30/2004 | CN1155383C Use of certain isoquinolinesulfonyl compounds for treatment of glaucoma and ocular ischemia |
| 06/30/2004 | CN1155382C Tablet with controlled release of alfuzosine chlorydrate |
| 06/30/2004 | CN1155379C Use of Yiliqutan in preparing medicine for preventing recurrence of cephalagra |
| 06/30/2004 | CN1155375C Linolic acid and linolenic acid capsule and its making process |
| 06/30/2004 | CN1155373C S-(3-hydroxypropyl)-L-cysteine composition as oral medicine |
| 06/30/2004 | CN1155372C Electrically assisted delivery conveyor and using method thereof |
| 06/30/2004 | CN1155371C Exactly divisible tablet |
| 06/30/2004 | CN1155370C Process for preparing medicinal granule |
| 06/30/2004 | CN1155369C Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 06/30/2004 | CN1155368C Powdery composition for nasal administration |
| 06/30/2004 | CN1155367C Micropartical inhalation formulations |
| 06/30/2004 | CN1155365C Nano-emulsion based on fatty glyceride and application thereof |
| 06/30/2004 | CN1155363C Composition for treatment of halitosis |
| 06/30/2004 | CA2454629A1 Amino acids in micelle preparation |
| 06/29/2004 | US6756508 Cinnamic acid salts, processes for their preparation, and their use as medicaments |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756472 Process for producing polymer |
| 06/29/2004 | US6756407 Administering a compound which acts on a mid-brain pathway to increase blood flow in the ilio-hypogastric-pudendal arterial bed and genitalia |
| 06/29/2004 | US6756363 Solutions and films of glycated chitosan |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756062 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 06/29/2004 | US6756059 Prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups containing at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic or hydroxyl groups |
| 06/29/2004 | US6756058 Sustained release drug delivery devices with multiple agents |
| 06/29/2004 | US6756057 Sustained release bilayer tablet providing both immediate and time delayed delivery |
| 06/29/2004 | US6756056 Use of a multilayer tablet comprising layer(s) of sustained release carbidopa-levodopa adjacent to layer(s) of immediate release of carbidopa-levodopa; dosage forms; oral drug delivery system |
| 06/29/2004 | US6756055 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells |
| 06/29/2004 | US6756054 Cholesterol carbamylated to straight chain polyamine |
| 06/29/2004 | US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 06/29/2004 | US6756052 Effects localized increase in temperature and/or blood flow using rubefacient agent |
| 06/29/2004 | US6756051 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same |
| 06/29/2004 | US6756049 Sustained release drug delivery devices |
| 06/29/2004 | US6756048 Long time drug-sustained release preparation |